| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/22/2009 | EP2050466A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 04/22/2009 | EP2050459A1 Prophylactic or therapeutic agent for viral disease |
| 04/22/2009 | EP2050458A1 IL24 for inducing hyperproliferative or autoimmune cell death |
| 04/22/2009 | EP2050455A1 Compounds leading to an increase of the IL-12/IL-10 ratio and their use for therapy of infectious and proliferative diseases |
| 04/22/2009 | EP2050452A1 indenoisoquinolines as topoisomerase inhibitors I useful as antineoplastic agents |
| 04/22/2009 | EP2050441A1 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| 04/22/2009 | EP2049563A2 Dimeric iap antagonists |
| 04/22/2009 | EP2049546A1 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049543A1 Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| 04/22/2009 | EP2049542A1 Pyrrolotriazine kinase inhibitors |
| 04/22/2009 | EP2049539A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same. |
| 04/22/2009 | EP2049530A2 Crystalline nemorubicin hydrochloride |
| 04/22/2009 | EP2049516A2 Pharmaceutical compounds |
| 04/22/2009 | EP2049503A1 Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| 04/22/2009 | EP2049502A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 04/22/2009 | EP2049501A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049500A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049491A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 04/22/2009 | EP2049490A1 N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl]-l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors |
| 04/22/2009 | EP2049480A1 2-arylindole derivatives as npges-i inhibitors |
| 04/22/2009 | EP2049201A2 Phosphate diester amides |
| 04/22/2009 | EP2049155A2 Antitumor combinations containing taxane derivatives |
| 04/22/2009 | EP2049154A1 Plasmids with immunological action |
| 04/22/2009 | EP2049151A2 Methods and compositions for the treatment of cancer |
| 04/22/2009 | EP2049147A2 Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy |
| 04/22/2009 | EP2049139A2 Treatment of ras-expressing tumors |
| 04/22/2009 | EP2049124A2 Phosphorus derivatives as histone deacetylase inhibitors |
| 04/22/2009 | EP2049121A1 Methods and compositions for promoting activity of anti-cancer therapies |
| 04/22/2009 | EP2049115A2 Alkyne-substituted pyridone compounds and methods of use |
| 04/22/2009 | EP2049109A2 Combined use of (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and cytarabine (ara-c) for the treatment of leukemia |
| 04/22/2009 | EP2049096A2 Method of treating chronic myelogenous leukemia cells |
| 04/22/2009 | EP2003140A9 Galactose derivative, drug carrier and medicinal composition |
| 04/22/2009 | EP2002832A9 Composition containing lignan compound |
| 04/22/2009 | EP1718651B1 7h-pyrrolopyrimidine derivatives |
| 04/22/2009 | EP1689404B9 Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer |
| 04/22/2009 | EP1587476A4 Novel compositions and methods in cancer |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1528925B1 Quinazoline derivatives for use in the treatment of cancer |
| 04/22/2009 | EP1505974B1 Use of compounds that are effective as selective opiate receptor modulators |
| 04/22/2009 | EP1468014B1 Compositions and methods for WT1 specific immunotherapy |
| 04/22/2009 | EP1424387B1 Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 04/22/2009 | EP1364069B1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 04/22/2009 | EP1299727B1 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 04/22/2009 | EP1200455B1 Enzyme catalyzed therapeutic activation |
| 04/22/2009 | EP1181319B1 Chimeric dr4 antibodies and uses thereof |
| 04/22/2009 | EP1089757B1 Hla binding peptides and their uses |
| 04/22/2009 | EP0882134B1 Methods and compositions for protective and therapeutic genetic immunization |
| 04/22/2009 | CN101415817A Entrapped stem cells and uses thereof |
| 04/22/2009 | CN101415730A Compositions and methods of use for antibodies of c-Met |
| 04/22/2009 | CN101415704A 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors |
| 04/22/2009 | CN101415695A Ceramide kinase modulation |
| 04/22/2009 | CN101415689A Substituted quinazolines with anti-cancer activity |
| 04/22/2009 | CN101415686A Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors |
| 04/22/2009 | CN101415679A Water-solubility CC-1065 analog and composition thereof |
| 04/22/2009 | CN101415440A Method for treating lung cancer |
| 04/22/2009 | CN101415434A Methods and compositions for the treatment of B cell lymphomas and other cancers |
| 04/22/2009 | CN101415431A A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 04/22/2009 | CN101415426A Use of c-Src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia |
| 04/22/2009 | CN101415424A Combinations comprising BCR-ABL/C-KIT/PDGF-R TK inhibitors for treating cancer |
| 04/22/2009 | CN101415422A Anti-cancer pharmaceutical composition |
| 04/22/2009 | CN101415417A Combination therapy of (2R,Z)-2-amino-2-cyclohexyl-N-(5-(1-methyl-1H-pyrazol-4-yl)-1-oxo-2,6-dihydro-1H-[1,2]diazepino[4,5,6-CD]indol-8-yl)acetamide |
| 04/22/2009 | CN101412959A Medical liquor |
| 04/22/2009 | CN101412759A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 04/22/2009 | CN101412758A Anti-ErbB2 antibodies |
| 04/22/2009 | CN101412749A MUC1 tandem repeat sequences polypeptide, preparation technique thereof and use as anti-tumor medicament |
| 04/22/2009 | CN101412744A Anti-angiogenic compositions and methods of use thereof |
| 04/22/2009 | CN101412743A 2 alpha-hydroxy-substituted white birch keto acid, preparation thereof and anti-tumor use |
| 04/22/2009 | CN101412742A Nitric acid ester medicament for inhibiting angiogenesis |
| 04/22/2009 | CN101412737A Anti-tumor bipyridine methyl substituted manganese amino acid complex, and preparation and application thereof |
| 04/22/2009 | CN101412732A Trihydrate 3-amino propyl amine ethyl phosphorothioic acid high purity stable crystal and preparation thereof |
| 04/22/2009 | CN101412726A Novel heterocyclic compounds |
| 04/22/2009 | CN101412696A 4,5-diaryl pyrazole-3-amido derivative, and preparation and use thereof |
| 04/22/2009 | CN101411879A SiO2/Au nano material with nucleocapsid structure-biological protein medicament complex and preparation method thereof |
| 04/22/2009 | CN101411877A Method for preparing thermosensitive nano medicament carrier with dual-target magnetism and folacin |
| 04/22/2009 | CN101411865A Use of compound acimetion enkephalins in preparing medicament for treating intestinal cancer and pancreatic cancer |
| 04/22/2009 | CN101411857A Pharmaceutical composition for treating cerebroma and cerebral concussion, and preparation method thereof |
| 04/22/2009 | CN101411854A External use medicament for eliminating cancer, tumor and sore thereof |
| 04/22/2009 | CN101411850A Chinese medicinal composition for treating cerebral apoplexy or cerebroma, Chinese medicament preparation, and preparation method thereof |
| 04/22/2009 | CN101411845A Cancer-suppressing analgesic medicament |
| 04/22/2009 | CN101411789A Novel use of Aquilaria sinensis fruit and extract thereof in preparing anti-tumor medicament |
| 04/22/2009 | CN101411787A Decoction medicament for treating rectum cancer induced hematochezia |
| 04/22/2009 | CN101411779A Chinese medicine effective component composition for treating liver cancer and method for preparing the same |
| 04/22/2009 | CN101411778A Chinese medicine effective component composition and method for preparing the same |
| 04/22/2009 | CN101411754A Anti-cancer oral liquid |
| 04/22/2009 | CN101411746A Novel use of salvia root extract |
| 04/22/2009 | CN101411744A Medicament for treating neoplastic disease |
| 04/22/2009 | CN101411739A Method for preparing Caesalpinia sappan water extract and uses thereof |
| 04/22/2009 | CN101411725A Anti-tumor halobios medicine for improving immunity function, and preparation method thereof |
| 04/22/2009 | CN101411720A Fungal medicinal granules for inducing suicide of cancer cell |
| 04/22/2009 | CN101411710A Pemetrexed disodium freeze-dried injection and preparation method thereof |
| 04/22/2009 | CN101411706A Pharmaceutical composition for resisting tumor of lung |
| 04/22/2009 | CN101411692A Etoposide dispersible tablet and preparation method thereof |
| 04/22/2009 | CN101411690A 2-methoxyestradiol lipidosome freeze-dried injection and preparation method thereof |
| 04/22/2009 | CN101411684A Injection containing pidotimod sodium salt |
| 04/22/2009 | CN101411476A Walnut oil health products for preventing breast cancer |
| 04/22/2009 | CN100480387C GBS toxin receptor |
| 04/22/2009 | CN100480272C Iluman wild type P53 fusion protein |
| 04/22/2009 | CN100480269C Anti-vegf antibodies |
| 04/22/2009 | CN100480264C Earthworm protein suppressing cancer cell accretion by road spectrum and coding sequence thereof |
| 04/22/2009 | CN100480263C Immunosuppressive receptor derived from dendritic cell, coding sequence and uses thereof |